Cytochalasin D

Cytochalasin D is a member of the cytochalasin family, a group of fungal metabolites that have the ability to inhibit actin polymerization in eukaryotic cells. This inhibition disrupts cellular processes such as cell division, cell motility, and the maintenance of cell shape, making cytochalasin D a valuable tool in cell biology and biomedical research.

Cytochalasin D specifically binds to the barbed end of actin filaments, preventing the addition of new actin monomers. This action not only halts filament elongation but also promotes filament disassembly, as the dynamic equilibrium of actin polymerization and depolymerization is shifted towards the latter. As a result, cells treated with cytochalasin D exhibit a range of morphological and functional changes, including altered cell shape, reduced cell motility, and inhibition of cell division.

The compound is widely used in laboratory studies to investigate the role of the actin cytoskeleton in various cellular processes. For example, it has been employed to study mechanisms of cell migration, cytokinesis, and the formation of cell junctions. Additionally, cytochalasin D has been used in cancer research to explore how alterations in cell motility and invasion contribute to tumor progression.

Despite its utility in research, cytochalasin D, like other cytochalasins, is a potent mycotoxin and poses potential health risks if not handled properly. It is important for researchers to use appropriate safety measures when working with this compound.

In summary, cytochalasin D is a critical tool in the study of the actin cytoskeleton, offering insights into fundamental cellular processes and disease mechanisms. Its ability to disrupt actin polymerization has made it an invaluable agent in cell biology and related fields.

Cytochalasin D Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.